| Code | 5899D | ||||||||||
| MA number | 26/0251/20-S | ||||||||||
| Product Form: | tbl ent 60x100 mg (fľ.HDPE) | ||||||||||
| MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
| Type of procedure: | Mutual recognition procedure | ||||||||||
| MAH, country: | STADA Arzneimittel AG, Germany | ||||||||||
| Therapeutic Class: | 26 - ANTIMYCOTICA (LOKÁLNE A CELKOVÉ) | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 36 | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product subject to restricted medical prescription. |
| Legal basis: | Article 10(1) generic application |
| MA issued: | 25.11.2020 |
| PIL: |
PIL_Posaconazole STADA 100 mg tbl ent_12.2024.pdf
|
| SPC: |
SPC_Posaconazole STADA 100 mg tbl ent_12.2024.pdf
|
| Safety feature | Yes |
| Data update: | 26.04.2024 |
